Cyclo Therapeutics, Inc. (CYTH)
USD 0.63
(-4.58%)
USD 0.63
(-4.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.07 Million | 1.37 Million | 1.58 Million | 903.37 Thousand | 1 Million | 1.01 Million |
| Cost of Revenue | 3.48 Million | 138.92 Thousand | 156.08 Thousand | 66.39 Thousand | 75.49 Thousand | 105.02 Thousand |
| Gross Profit | -2.41 Million | 1.23 Million | 1.42 Million | 836.97 Thousand | 931.7 Thousand | 906.45 Thousand |
| Operating Expenses | 21.04 Million | 16.84 Million | 15.69 Million | 9.79 Million | 8.32 Million | 5.16 Million |
| Selling, General and Administrative Expenses | 5.66 Million | 7.81 Million | 6.51 Million | 3.68 Million | 3.43 Million | 2.43 Million |
| Research and Development Expenses | 14.18 Million | 8.99 Million | 9.15 Million | 6.09 Million | 4.86 Million | 2.71 Million |
| Other Expenses | - | 30.5 Thousand | 27.53 Thousand | 19.95 Thousand | 13.97 Thousand | 13.94 Thousand |
| Cost and Expenses | 21.12 Million | 16.98 Million | 15.85 Million | 9.86 Million | 8.39 Million | 5.26 Million |
| Operating Income | -20.05 Million | -15.61 Million | -14.26 Million | -8.96 Million | -7.39 Million | -4.26 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -170.99 Thousand | 18.52 Thousand | -18.53 Thousand | 141.74 Thousand | 11.77 Thousand |
| Earnings before Tax | -20.05 Million | -15.45 Million | -14.28 Million | -8.94 Million | -7.53 Million | -4.25 Million |
| Net Income | -20.05 Million | -15.27 Million | -14.3 Million | -8.92 Million | -7.67 Million | -4.25 Million |
| Earnings Per Share Basic | -1.23 | -1.81 | -2.25 | -5.58 | -7.09 | -5.20 |
| Earnings Per Share Diluted | -1.23 | -1.81 | -2.25 | -5.58 | -7.09 | -5.20 |
| Weighted Average Shares Outstanding | 16.32 Million | 8.43 Million | 6.37 Million | 1.59 Million | 1.08 Million | 817.56 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 16.32 Million | 8.43 Million | 6.37 Million | 1.59 Million | 1.08 Million | 817.56 Thousand |
| Gross Margin | -2.24 | 0.90 | 0.90 | 0.93 | 0.93 | 0.90 |
| EBIT Margin | -18.61 | -11.45 | -8.98 | -9.92 | -7.19 | -4.20 |
| Profit Margin | -18.63 | -11.11 | -9.02 | -9.88 | -7.62 | -4.21 |
| EBITDA | -20.03 Million | -15.6 Million | -14.26 Million | -8.94 Million | -7.38 Million | -4.24 Million |
| Earnings Before Tax Margin | -18.63 | -11.35 | -9.00 | -9.92 | -7.34 | -4.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 123.1 Thousand | 202.45 Thousand | 311.39 Thousand | 1.07 Million | 495.47 Thousand | 117.11 Thousand |
| Cost of Revenue | 931.12 Thousand | 836.48 Thousand | 876.55 Thousand | 3.48 Million | 38.76 Thousand | 19.9 Thousand |
| Gross Profit | -808.02 Thousand | -634.03 Thousand | -565.15 Thousand | -2.41 Million | 456.71 Thousand | 97.2 Thousand |
| Operating Expenses | 4.82 Million | 4.47 Million | 5.07 Million | 17.63 Million | 5.22 Million | 4.73 Million |
| Selling, General and Administrative Expenses | 1.33 Million | 1.62 Million | 933.03 Thousand | - | 1.52 Million | 1.27 Million |
| Research and Development Expenses | 3.49 Million | 2.84 Million | 4.14 Million | - | 3.46 Million | 3.17 Million |
| Other Expenses | -149.68 Thousand | 540.43 Thousand | -2.3 Million | - | 1.15 Million | 1.14 Million |
| Cost and Expenses | 5.75 Million | 5.31 Million | 5.95 Million | 21.12 Million | 5.26 Million | 4.75 Million |
| Operating Income | -5.63 Million | -5.1 Million | -5.64 Million | -20.05 Million | -4.76 Million | -4.63 Million |
| Interest Expense | - | - | 47.00 | - | - | - |
| Income Tax Expense | 3.00 | 3.00 | 1.00 | 4.00 | 3893.00 | 3513.00 |
| Earnings before Tax | -5.98 Million | -4.34 Million | -5.64 Million | -20.05 Million | -4.77 Million | -4.63 Million |
| Net Income | -5.98 Million | -4.34 Million | -5.64 Million | -20.05 Million | -4.77 Million | -4.63 Million |
| Earnings Per Share Basic | -0.21 | -0.15 | -0.23 | - | -0.29 | -0.33 |
| Earnings Per Share Diluted | -0.21 | -0.15 | -0.23 | - | -0.29 | -0.33 |
| Weighted Average Shares Outstanding | 28.63 Million | 28.58 Million | 24.86 Million | 16.32 Million | 16.19 Million | 14.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.63 Million | 28.58 Million | 24.86 Million | 16.32 Million | 16.19 Million | 14.04 Million |
| Gross Margin | -6.56 | -3.13 | -1.81 | -2.24 | 0.92 | 0.83 |
| EBIT Margin | -45.76 | -25.23 | -18.10 | - | -9.60 | -39.49 |
| Profit Margin | -48.59 | -21.45 | -18.12 | -18.63 | -9.63 | -39.59 |
| EBITDA | -5.63 Million | -5.1 Million | -5.63 Million | - | -4.75 Million | -4.62 Million |
| Earnings Before Tax Margin | -45.78 | -25.24 | -18.12 | -18.63 | -9.62 | -39.56 |
2768
MUR
ENEA
RIO
NVMLF
600643